MediFind found 6 doctor with experience in Autosomal Dominant Tubulointerstitial Kidney Disease near Hokkaido, JP. Of these, 6 are Experienced.
Norihito Moniwa practices in Sapporo, Japan. Moniwa is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. Their top areas of expertise are Goodpasture Syndrome, Light Chain Deposition Disease (LCDD), Hypertension, and Glomerulonephritis.
Saori Nishio practices in Sapporo, Japan. Ms. Nishio is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. Her top areas of expertise are Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Necrotizing Vasculitis, Minimal Change Disease, and Liver Embolization.
Mitsuru Yanai practices in Sapporo, Japan. Mr. Yanai is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. His top areas of expertise are Acute Tubular Necrosis, Pulmonary Edema, Sepsis, Glomerulonephritis, and Kidney Transplant.
Fumihiko Hattanda practices in Sapporo, Japan. Hattanda is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. Their top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Vasculitis, Microscopic Polyangiitis, and Liver Embolization.
Masayoshi Miura practices in Sapporo, Japan. Mr. Miura is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. His top areas of expertise are Autosomal Dominant Tubulointerstitial Kidney Disease, Hydronephrosis, Membranoproliferative Glomerulonephritis, Kidney Transplant, and Nephrectomy.
Marenao Tanaka practices in Sapporo, Japan. Tanaka is rated as an Experienced expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. Their top areas of expertise are End-Stage Renal Disease (ESRD), Hypertension, Non-Alcoholic Fatty Liver Disease, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).
Last Updated: 01/09/2026